Furthermore, the sarcomatous component of the tumor was positive for HHF, myogenin, and caldesmon, whereas the epithelial component was diffusely positive for inhibin, melan-A, S-100 protein, NSE and HMB-45. The gene discussed is MLANA; the disease is neoplasm.